Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Albiglutide 50 mg powder for solution for injection pen |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Albiglutide 50 mg powder for solution for injection pen |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
3 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Trastuzumab 440 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Trastuzumab 440 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 20 microgram/mL solution for injection |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 20 microgram/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Sodium chloride 9 mg/mL solution for ocular irrigation |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Sodium chloride 9 mg/mL solution for ocular irrigation |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Drotrecogin alfa 5 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Drotrecogin alfa 5 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
3 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Interferon beta-1a 30 microgram/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Interferon beta-1a 30 microgram/mL solution for injection |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
3 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |